Concepedia

Author

Philipp Schmid

Roche (Switzerland)ORCID

Also Known As

Philipp Schmid

12

Publications

357

Citations

7

H-Index

14

Concepts

All Affiliations

Roche (Switzerland)University of Konstanz
PS

About

Philipp Schmid is an author at Roche (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

200

2

Natural Sciences

2

2

67

3

Biochemistry

2

2

67

4

Social Sciences

1

1

133

5

Neuroscience

1

1

133

Philipp Schmid

×

6

Publications

331

Citations

6

H-Index

YearCitations

Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((<i>S</i>)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia

Emmanuel Pinard, Alexander Alanine, Daniela Alberati,

Journal of Medicinal Chemistry

2010

133

Mechanistic Studies of Fatty Acid Activation by CYP152 Peroxygenases Reveal Unexpected Desaturase Activity

Mathias Pickl, Sara Kurakin, Fabián G. Cantú Reinhard,

ACS Catalysis

2018

98

Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists

Guido Galley, Angélica Beurier, Guillaume Décoret,

ACS Medicinal Chemistry Letters

2015

50

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2

Lilian Peñalver, Philipp Schmid, Dávid Szamosvári,

Angewandte Chemie International Edition

2020

19

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors

Emmanuel Pinard, Daniela Alberati, Markus Bender,

Bioorganic & Medicinal Chemistry Letters

2010

17

Close the ring to break the cycle: tandem quinolone-alkyne-cyclisation gives access to tricyclic pyrrolo[1,2-<i>a</i>]quinolin-5-ones with potent anti-protozoal activity

Dávid Szamosvári, Kayla Sylvester, Philipp Schmid,

Chemical Communications

2019

14

Page 1